UTI Healthcare Fund - Regular Plan - Growth has delivered CAGR and average rolling returns as follows :
| 1 Year | 3 Year | 5 Year | 9 Year | |
| CAGR(%) | 1.11 | 23.67 | 14.24 | 13.1 |
| Average Rolling Returns(%) | 16.67 | 12.76 | 13.19 | 13.24 |
The Current NAV of UTI Healthcare Fund - Regular Plan - Growth is ₹280.14.
You should look for a fund with better more consistent performance track record. Funds returns are more likely to be different than its benchmark NIFTY 500 returns, as Funds portfolio is significantly different.
UTI Healthcare Fund - Regular Plan - Growth fund’s expense ratio is 2.28%
The process for redemption is
The AUM of UTI Healthcare Fund - Regular Plan - Growth is currently ₹1,056 Crores.
The Top three stocks are Sun Pharma Inds., Ajanta Pharma and Lupin and account for 22% of its portfolio. Top 5 and 10 stocks of fund account for 30% and 47% of fund’s portfolio respectively.
Top three sectors of UTI Healthcare Fund - Regular Plan - Growth fund are Healthcare, Miscellaneous and accounting for 100% of the total portfolio.
Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.
The category of UTI Healthcare Fund - Regular Plan - Growth Fund is Equity - Sectoral Fund - Pharma & Health Care.
Kamal Gada manages the UTI Healthcare Fund - Regular Plan - Growth Fund.
UTI Healthcare Fund - Regular Plan - Growth current PE ratio is 45.12 and PB ratio is 6.38
The asset allocation of UTI Healthcare Fund - Regular Plan - Growth is Stocks : 98.66%, Debt : 1.33% and Gold : 0%
The minimum SIP amount for UTI Healthcare Fund - Regular Plan - Growth is ₹500.00 and minimum lumpsum is ₹5000.00
The exit load for UTI Healthcare Fund - Regular Plan - Growth is 1% on or before 30 days, Nil after 30 days
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: